mProX™ Human YES1 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Kinase Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryProduct Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
There are currently no Customer reviews or questions for mProX™ Human YES1 Stable Cell Line (S01YF-1023-PY134). Click the button above to contact us or submit your feedback about this product.
Jordan Garcia (Verified Customer)
Patrick Liam (Creative Biolabs Scientific Support)
Jordan Miller (Verified Customer)
Patrick Liam (Creative Biolabs Scientific Support)
Published Data
Fig.1 YES1 promotes GC cell proliferation.
In the upper panel, we conducted CCK8 analysis to assess the proliferation of MGC-803 cells overexpressing YES1 and AGS cells with YES1 knockdown, comparing them to their respective control groups. In the lower panel, we present representative images and quantitative data from a soft agar colony formation assay, which illustrates the impact of YES1 overexpression in MGC-803 cells and YES1 knockdown in AGS cells, alongside their respective control counterparts.
Ref: Mao, Linfeng, et al. "EphA2-YES1-ANXA2 pathway promotes gastric cancer progression and metastasis." Oncogene 40.20 (2021): 3610-3623.
Pubmed: 33941853
DOI: 10.1038/s41388-021-01786-6
Research Highlights
Zhang, Ruzhen. et al. "Actin polymerization inhibition by targeting ARPC2 affects intestinal stem cell homeostasis." Burns & trauma, 2023.
In this research, the focus is on the turnover of intestinal epithelial cells driven by intestinal stem cells and the role of F-actin cytoskeleton dynamics in this process. They investigate the impact of benproperine (BPP), an anti-tumor drug, on this homeostasis. The study utilizes various methods, including fluorescence staining, flow cytometry, and organoid culture, to assess cell proliferation, differentiation, and migration. Results show that F-actin content increases during cell migration, particularly in Paneth cells, and BPP treatment affects organoid growth, cell proliferation, and gene expression related to intestinal stem cells and Paneth cell differentiation. This suggests a potential novel approach using BPP to influence intestinal epithelial cell turnover through cytoskeleton regulation.
Zhang, Ruzhen. et al. "Actin polymerization inhibition by targeting ARPC2 affects intestinal stem cell homeostasis." Burns & trauma, 2023.
Pubmed:
37849945
DOI:
10.1093/burnst/tkad038
Enokido, Takayoshi. et al. "Distinct microRNA signature and suppression of ZFP36L1 define ASCL1-positive lung adenocarcinoma." Molecular cancer research : MCR, 2023.
Achaete-scute family bHLH transcription factor 1 (ASCL1) serves as a key transcription factor in neuroendocrine differentiation and is found in roughly 10% of lung adenocarcinomas, contributing to tumor progression. The study delved into the microRNA (miRNA) patterns in ASCL1-positive lung adenocarcinomas and pinpointed several closely linked miRNAs, including miR-375, miR-95-3p/miR-95-5p, miR-124-3p, and members of the miR-17~92 family. These findings mirror the suppression of Yes1 associated transcriptional regulator (YAP1), a notable target of miR-375, observed in ASCL1-positive lung adenocarcinomas. The research also highlighted ASCL1's positive influence on miR-124-3p and miR-17~92 family members, underscoring ZFP36 ring finger protein like 1 (ZFP36L1) as a miR-124-3p target gene, while demonstrating low ZFP36L1 protein levels in ASCL1-positive lung adenocarcinomas. This study disclosed that the downregulation of ZFP36L1 by ASCL1-controlled miR-124-3p can impact gene expression, elucidating the role of ASCL1 in shaping the molecular characteristics of ASCL1-positive lung adenocarcinomas and suggesting potential clinical implications.
Enokido, Takayoshi. et al. "Distinct microRNA signature and suppression of ZFP36L1 define ASCL1-positive lung adenocarcinoma." Molecular cancer research : MCR, 2023.
Pubmed:
37801008
DOI:
10.1158/1541-7786.MCR-23-0229